Latest Breaking News On - Impel neuropharma inc - Page 6 : comparemela.com
The Buzz Show: Impel NeuroPharma, Inc (NASDAQ: IMPL) FDA Approval for Acute Migraine Treatment
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
FDA Approves Intranasal DHE (Trudhesa) for Acute Migraine
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
This analyst raised price target on Impel NeuroPharma by more than 50%
invezz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invezz.com Daily Mail and Mail on Sunday newspapers.
North American Morning Briefing: Weak Chinese -3-
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Impel NeuroPharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.